# SharonAI Holdings Inc.: financial statements, quarterly

SHAZ · Nasdaq · CIK 2068385 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/shaz.md) · [Financials](/companies/shaz/financials.md) · [Filings](/companies/shaz/filings.md) · [Insiders](/companies/shaz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/shaz/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.3](/filings/0001493152-26-023769.md) | [0.4](/filings/0001493152-26-037202.md) | [0.3](/filings/0001493152-26-023769.md) | [1.9](/filings/0001493152-26-037202.md) |
| Cost of revenue | $m | [0.3](/filings/0001493152-26-023769.md) | [0.4](/filings/0001493152-26-037202.md) | [0.5](/filings/0001493152-26-023769.md) | [0.8](/filings/0001493152-26-037202.md) |
| Gross profit | $m | [0.0](/filings/0001493152-26-023769.md) | [(0.0)](/filings/0001493152-26-037202.md) | [(0.2)](/filings/0001493152-26-023769.md) | [1.2](/filings/0001493152-26-037202.md) |
| Selling, general and administrative | $m | [1.0](/filings/0001493152-26-023769.md) | [1.1](/filings/0001493152-26-037202.md) | [4.0](/filings/0001493152-26-023769.md) | [8.7](/filings/0001493152-26-037202.md) |
| Operating income | $m | [(1.2)](/filings/0001493152-26-023769.md) | [(2.6)](/filings/0001493152-26-037202.md) | [(2.8)](/filings/0001493152-26-023769.md) | [(24.8)](/filings/0001493152-26-037202.md) |
| Interest expense | $m | not reported | [0.0](/filings/0001493152-26-037202.md) | not reported | [4.5](/filings/0001493152-26-037202.md) |
| Income tax | $m | [(0.1)](/filings/0001493152-26-023769.md) | [(0.1)](/filings/0001493152-26-037202.md) | [13.5](/filings/0001493152-26-023769.md) | [1.3](/filings/0001493152-26-037202.md) |
| Net income | $m | [(1.4)](/filings/0001493152-26-023769.md) | [(2.6)](/filings/0001493152-26-037202.md) | [(19.9)](/filings/0001493152-26-023769.md) | [(428)](/filings/0001493152-26-037202.md) |
| Diluted EPS | $ per share | [(1.34)](/filings/0001493152-26-023769.md) | [(0.27)](/filings/0001493152-26-037202.md) | [(1.43)](/filings/0001493152-26-023769.md) | [(22.84)](/filings/0001493152-26-037202.md) |
| Basic EPS | $ per share | [(1.34)](/filings/0001493152-26-023769.md) | [(0.27)](/filings/0001493152-26-037202.md) | [(1.43)](/filings/0001493152-26-023769.md) | [(22.84)](/filings/0001493152-26-037202.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [4.4](/filings/0001493152-26-014068.md) | not reported | not reported | [71.1](/filings/0001493152-26-036377.md) | [164](/filings/0001493152-26-023769.md) | [1,861](/filings/0001493152-26-036377.md) |
| Current assets | $m | not reported | [6.2](/filings/0001493152-26-014068.md) | not reported | not reported | [88.4](/filings/0001493152-26-036377.md) | [231](/filings/0001493152-26-023769.md) | [1,938](/filings/0001493152-26-036377.md) |
| Total assets | $m | not reported | [32.1](/filings/0001493152-26-014068.md) | not reported | not reported | [133](/filings/0001493152-26-036377.md) | [314](/filings/0001493152-26-023769.md) | [2,321](/filings/0001493152-26-036377.md) |
| Current liabilities | $m | not reported | [1.1](/filings/0001493152-26-014068.md) | not reported | not reported | [139](/filings/0001493152-26-036377.md) | [221](/filings/0001493152-26-023769.md) | [184](/filings/0001493152-26-036377.md) |
| Total liabilities | $m | not reported | [2.2](/filings/0001493152-26-014068.md) | not reported | not reported | [143](/filings/0001493152-26-036377.md) | [225](/filings/0001493152-26-023769.md) | [1,194](/filings/0001493152-26-036377.md) |
| Shareholders' equity | $m | [0.0](/filings/0001493152-26-014068.md) | [29.9](/filings/0001493152-26-037202.md) | [28.8](/filings/0001493152-26-037202.md) | [26.5](/filings/0001493152-26-037202.md) | [(10.1)](/filings/0001493152-26-037202.md) | [88.6](/filings/0001493152-26-037202.md) | [1,128](/filings/0001493152-26-037202.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.3)](/filings/0001493152-26-023769.md) | [(0.4) d](/filings/0001493152-26-036377.md) | [(7.4)](/filings/0001493152-26-023769.md) | [30.7 d](/filings/0001493152-26-036377.md) |
| Capital expenditure | $m | [0.0](/filings/0001493152-26-023769.md) | [0.0 d](/filings/0001493152-26-036377.md) | [0.1](/filings/0001493152-26-023769.md) | [12.5 d](/filings/0001493152-26-036377.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1.1](/filings/0001493152-26-023769.md) | [9.7](/filings/0001493152-26-037202.md) | [14.0](/filings/0001493152-26-023769.md) | [18.8](/filings/0001493152-26-037202.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.